• Who we are
    • Medicines for Europe
    • Purpose and Objectives
    • OUR VALUES
    • STRUCTURE
    • OUR MEMBERS
    • BECOME A MEMBER
    • CODE OF CONDUCT
    • DISCLOSURE
    • JOB OPPORTUNITIES
  • Key topics
    • COVID-19
    • Access
    • INDUSTRIAL POLICY
    • REGULATORY AND LEGAL FRAMEWORK
    • FALSIFIED MEDICINES
    • ENVIRONMENT
    • ANTIMICROBIAL RESISTANCE
    • MEDICINE SHORTAGES
  • Publications
    • Factsheets
    • Infographics
    • Reports
    • Policy
    • Videos
    • Podcast
  • Newsroom
    • Press releases
    • In the news
    • Press kit
  • Contact us
Login Login
Medicines for Europe
  • Generic medicines
    • Home
    • Who we are
      • Generic medicines Group
      • MISSION AND VISION
      • STRUCTURE
      • MEMBERS
      • BECOME A MEMBER
    • Did you know?
      • Definition
      • THERAPEUTIC AREAS
      • GLOSSARY
      • Q&A
    • What’s new
      • FACTSHEETS
      • POLICY
      • REPORTS
      • VIDEOS
      • INFOGRAPHICS
    • Our 5 pillars
      • Patients
      • QUALITY
      • VALUE
      • SUSTAINABILITY
      • PARTNERSHIP
    • Find out more
      • Related links
      • Contact us
    • Twitter
  • Biosimilar medicines
    • Home
    • Who we are
      • Biosimilar medicines Group
      • MISSION AND VISION
      • STRUCTURE
      • MEMBERS
      • BECOME A MEMBER
    • Did you know?
      • DEFINITION
      • THERAPEUTIC AREAS
      • GLOSSARY
      • Q&A
    • What’s new
      • FACTSHEETS
      • POLICY
      • REPORTS
      • VIDEOS
      • INFOGRAPHICS
      • External resources
    • Our 5 pillars
      • Patients
      • QUALITY
      • VALUE
      • SUSTAINABILITY
      • PARTNERSHIP
    • Find out more
      • Related links
      • Contact us
    • Twitter
  • Value added medicines
    • Home
    • Who we are
      • Value added medicines Group
      • MISSION AND VISION
      • STRUCTURE
      • MEMBERS
      • BECOME A MEMBER
    • Did you know?
      • Environment of value added medicines in Europe
      • Definition
      • THERAPEUTIC AREAS
      • Q&A
    • What’s new
      • Environment of value added medicines in Europe
      • FACTSHEETS
      • POLICY
      • REPORTS
      • VIDEOS
      • INFOGRAPHICS
      • Value Added Medicines award 2019
      • QUOTES
    • Our 5 pillars
      • Patients
      • QUALITY
      • VALUE
      • SUSTAINABILITY
      • PARTNERSHIP
    • Find out more
      • Contact us
  • Events

10th Medicines for Europe Pharmacovigilance Conference. Save the date!

25 November 2016

Related Posts

  • Industry Coming Together To Improve Safety For Patients 26 January 2016 London - In London this week, the European Generic and Biosimilar medicines…
  • Launch of European Value Added medicines (EVA), a new EGA… 12 June 2015 Brussels - The European Generic and Biosimilar medicines Association (EGA) announced…
  • Launch of European Value Added medicines (EVA), a new EGA… 12 June 2015 Brussels - The European Generic and Biosimilar medicines Association (EGA) announced…
  • Generic medicines have enabled twice as many patients to get 12 October 2016 Presentation of the report “The Value of Generic Medicines” GENERIC…
Share this
Share on Facebook
Facebook
Share on Google+
Google+
Tweet about this on Twitter
Twitter
Share on LinkedIn
Linkedin
Pin on Pinterest
Pinterest
Buffer this page
Buffer
Email this to someone
email
Medicines for Europe
MEMBER OF
IGBA EMVO
  • Contact us
  • Privacy Policy
Medicines for Europe AISBL
Rue d’Arlon 50
1000 Brussels Belgium
T : +32 (0)2 736 84 11
Powered by Big Smile Agency
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok